Original Research
Published on 18 Feb 2026
Systems-level molecular and immunological evidence identifies Th17/Treg modulation as a key mechanism of CRSJ’s neuroprotection in Parkinson’s disease
in Parkinson’s Disease and Aging-related Movement Disorders
- 138 views